Multisector Collaborations and Global Oncology: The Only Way Forward
Charmaine Blanchard 1, Buhle Lubuzo 2, Frederick Chite Asirwa 3, Xolisile Dlamini 4, Susan C Msadabwe-Chikuni 5, Michael Mwachiro 6, Cyprien Shyirambere 7, Deo Ruhangaza 7, Dan A Milner Jr 8, Katherine Van Loon 9, Rebecca DeBoer 9, Phangisile Mtshali 10, Ute Dugan 11, Ellen Baker 12, Lawrence N Shulman 13
At the 12th meeting of AORTIC (African Organization for Research and Training in Cancer) in Maputo, Mozambique, held between November 5 and November 8, 2019, a special workshop was organized to focus on the need for collaboration and coordination between governments and health systems in Africa with academic, industry, association, and other nongovernmental organizations to effect sustainable positive change for the care of patients with cancer..
Global costs, health, and economic benefits of scaling up treatment and imaging modalities for survival of 11 cancers: a simulation-based analysis
Zachary J Ward, PhDa , Prof Andrew M Scott, MDc,d,e,f , Prof Hedvig Hricak, MDg , Prof Rifat Atun, FRCPb,h
Using a previously developed model of global cancer survival, we estimated stage-specific cancer survival and life-years gained (accounting for competing mortality) in 200 countries and territories for patients diagnosed with one of 11 cancers representing 60% of all cancer diagnoses between 2020 and 2030. We evaluated the costs and health and economic benefits of scaling up packages of treatment.
Advancing oncology drug therapies for sub-Saharan Africa
Kirthana Sharma,Tina Mayer, Sharon Li, Sadaf Qureshi, Faheem Farooq, Peter Vuylsteke, Tlotlo Ralefala, Richard Marlink
A review of selected oncology drug therapies that are likely to benefit cancer patients with a focus on common malignancies in SSA. We collected available data from seminal clinical trials in high-income countries to highlight the potential for these therapeutics to improve cancer outcomes.
Addressing cancer care inequities in sub-Saharan Africa: current challenges and proposed solutions
Olabode Omotoso’, John Oluwafemi Teibo 2*, Festus Adebayo Atiba, Tolulope Oladimeji. Oluwatomiwa Kehinde Paimo*, Farid S. Ataya, Gaber El-Saber Batiha, Athanasios Alexiou
Using available literature, we provide an overview of the current state of cancer care in Africa and recommendations to close the gap.
Global Survey of Clinical Oncology Workforce
Aju Mathew
The aim of this study was to survey and describe the availability of clinical oncologists around the world
Cancer control in Ghana: A narrative review in global context
Kofi Boamah Mensah, Adwoa Bemah Boamah Mensah
Explaining disparities in oncology health systems delays and stage at diagnosis between men and women in Botswana: A cohort study
Hari S. Iyer, Racquel E. Kohler, Doreen Ramogola-Masire, Carolyn Brown, Kesaobaka Molebatsi, Surbhi Grover, Irene Kablay, Memory Bvochora-Nsingo, Jason A. Efstathiou, Shahin Lockman, Neo Tapela, Scott L. Dryden-Peterson
Cancer patients who initiated oncology treatment between October 2010 and June 2017 were recruited at four oncology centers in Botswana. Primary outcomes were time from first visit with cancer symptom to treatment initiation, and advanced cancer (stage III/IV). Sociodemographic and clinical covariates were obtained retrospectively through interviews and medical record review.
Go Together 